News

June 24, 2019June 24, 2019

New Genentech Study to Investigate Familial Alzheimer’s Progression and Response to Crenezumab

News

Genentech, a subsidiary of Roche, has launched a new substudy to learn more about the progression of early-onset familial Alzheimer’s disease, as part of its ongoing Alzheimer’s Prevention Initiative (API) ... Read more

June 21, 2019June 21, 2019

1st U.S. Patient Enrolled in Phase 2a Trial Evaluating Vafidemstat for Alzheimer’s

News

A Phase 2a trial testing Oryzon’s investigational therapy vafidemstat for Alzheimer’s disease has enrolled its first patient in the U.S. The trial (NCT03867253), called ETHERAL-US, is an extension of ... Read more

June 19, 2019June 19, 2019

Vaccine Reduces Tau Tangle Formation, Improves Cognitive Functioning in Alzheimer’s Mouse Model

News

A vaccine produced using virus-like particles was able to improve cognitive functioning and reduce the accumulation of tau protein aggregates — a hallmark of Alzheimer’s disease — in a ... Read more

June 17, 2019June 17, 2019

Presence of Mouth Bacteria Linked to Risk of Alzheimer’s, Study Shows

News

A connection discovered between Alzheimer’s and the bacteria that cause gum disease suggests that improved oral hygiene may decrease the risk of developing the disorder, a study reports. The ... Read more

June 14, 2019June 14, 2019

AxoSim Licenses Mini-Brain Technology to Pursue Therapies for Alzheimer’s, Other Disorders

News

AxoSim has acquired exclusive rights to lab-grown brain miniatures, coined “Mini-Brain,” a technology developed at Johns Hopkins University that uses stem cells to create models of the human brain in a ... Read more

June 12, 2019June 12, 2019

Host of Activities Planned for Alzheimer’s and Brain Awareness Month

News

Scores of efforts to mark June’s Alzheimer’s & Brain Awareness Month are designed to raise funds and visibility around the degenerative brain disease and related disorders, and the estimated ... Read more

June 10, 2019

High Levels of ‘Bad’ Cholesterol Linked to Increased Risk of Early-onset Alzheimer’s, Study Suggests

News

High levels of “bad” cholesterol, known as low-density lipoprotein (LDL), might increase the risk of developing early-onset Alzheimer’s disease, a study suggests. The study, “Association of Early-Onset Alzheimer Disease ... Read more

June 7, 2019June 7, 2019

ProMIS’ PMN310 Antibody Candidate Shows Greater Effect, Less Risk Than Other Therapies, According to Data

News

ProMIS Neurosciences’ candidate PMN310 can specifically target toxic clusters of soluble amyloid-beta protein, and be safely administered at high doses with reduced risk of characteristic Alzheimer’s brain changes or ... Read more

June 5, 2019June 5, 2019

Alzheimer’s Diagnostics Accelerator Program Awards Nearly $3.5M to Develop Early-detection Methods

News

Selected through the Alzheimer’s Drug Discovery Foundation’s (ADDF) Diagnostics Accelerator program, four scientists will share nearly $3.5 million to develop new biomarkers for early detection of Alzheimer’s disease and related dementia. ... Read more

June 3, 2019June 3, 2019

Virtual Reality May Improve Quality of Life of Hospitalized Dementia Patients, Study Says

News

Virtual reality may help improve the quality of life for people with dementia, including those with Alzheimer’s disease, by stimulating them to recall past memories, reduce aggressive behavior, and ... Read more

Pin It on Pinterest